to find the utility of parasikayavanyadi capsule in sleeplesness
- Conditions
- Health Condition 1: null- INSOMNIA
- Registration Number
- CTRI/2012/12/003174
- Lead Sponsor
- AYUSH
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 50
patients suffering from following type of disturbed sleep pattern
Sleep onset insomnia Difficulty taking sleep at the beginning of the night
Sleep maintenance insomnia Difficulty maintain the sleep
Nocturnal awakenings Difficulty to retuning to sleep after awakening in the middle of the night or wakening early in the morning
Rebound insomnia Patients who has developed dependence to sedatives
Circadian rhythm disorders Sleeping pattern changes
Patients having insomnia more than 2 weeks less than 6 months
Patients of insomnia with mild hypertension
mild depression and anxiety disorders without any complaints of any other major diseases
patients less than 16 years and more than 75 years
Patients suffering from fatal familial insomnia Insomnia with major psychiatric illness like Schizophrenia depressive psychosis Epilepsy
Patients having advanced chronic illness like Bronchial asthma Diabetes mellitus malignancy Liver cirrhosis chronic renal failure
Patients with alcohol or drug dependency will be excluded
Patients having acute illness like cardiovascular accidents myocardial infarction chronic obstructive pulmonary disease Pregnant woman and planning to be pregnant within six months
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method PITTSBURGH INSOMNIA RATING SCALE <br/ ><br>HAMILTONS ANXIETY RATING SCALE <br/ ><br>HAMILTON DEPRESSION RATING SCALE <br/ ><br>HOLEMS AND RAHES STRESS RATING SCALE <br/ ><br>S CORTISOL LEVEL ANALYSIS FOR DRUG EFFECT AS AN OBJECTIVE CRITIRIEATimepoint: EFFECT OF DRUG IS ASSED AFTER ONE MONTH
- Secondary Outcome Measures
Name Time Method ILTimepoint: NI